Ostia Sciences Inc. Secures Over $1 Million CAD in Seed Investment Round, Finalizes IP Assignment with the University of Toronto, and Prepares First Prototype for Groundbreaking Microbiome Technology

These milestones position Ostia Sciences at the forefront of oral probiotics and biotherapeutics development. Read More